Lin Ning
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lin Ning has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Hao Lin
School of Life Science and Technology and Center for Informational Biology, University of Electronic Science and Technology of China, Chengdu 610054, China
3 shared publications - Hasan Zulfiqar
Yangtze Delta Region Institute (Huzhou), University of Electronic Science and Technology of China, Huzhou, China
2 shared publications - Nanchao Luo
School of Computer Science and Technology Aba Teachers College Aba Sichuan China
2 shared publications Yang Zhang
Innovative Institute of Chinese Medicine and Pharmacy Academy for Interdiscipline Chengdu University of Traditional Chinese Medicine Chengdu China
2 shared publicationsBaocai Zhong
School of Computer and Software, Chengdu Neusoft University, Chengdu, China
1 shared publication- Basharat Ahmad
School of Life Science and Technology and Center for Informational Biology, University of Electronic Science and Technology of China, Chengdu 610054, China
1 shared publication
Latest Publications
- Open Access
- 14 November 2024
- Published by Institution of Engineering and Technology (IET) in IET Systems Biology
- Vol. 18 (6) , 199-207
siRNAEfficacyDB: An experimentally supported small interfering RNA efficacy database
Small interfering RNA (siRNA) has revolutionised biomedical research and drug development through precise post‐transcriptional gene silencing technology. Despite its immense potential, siRNA therapy still faces technical challenges, such as delivery efficiency, targeting specificity, and molecular stability. To address these challenges and facilitate siRNA drug development, we have developed siRNAEfficacyDB, a comprehensive database that integrates experimentally validated siRNA efficacy data. This database contains 3544 siRNA records, covering 42 target genes and 5 cell lines. It provides detailed information on siRNA sequences, target genes, inhibition efficiencies, experimental techniques, cell lines, siRNA concentrations, and incubation times. siRNAEfficacyDB offers a user‐friendly web interface that makes it easy to query, browse and analyse data, enabling efficient access to siRNA‐related information. In summary, siRNAEfficacyDB provides a useful data foundation for siRNA drug design and optimisation, serving as a valuable resource for advancing computer‐aided siRNA design research and nucleic acid drug development. siRNAEfficacyDB is freely available at https://cellknowledge.com.cn/siRNAEfficacy for non‐commercial use.
- 14 November 2024
- Published by Institution of Engineering and Technology (IET) in IET Systems Biology
- Vol. 18 (6) , 199-207
Open AccesssiRNAEfficacyDB: An experimentally supported small interfering RNA efficacy database
Small interfering RNA (siRNA) has revolutionised biomedical research and drug development through precise post‐transcriptional gene silencing technology. Despite its immense potential, siRNA therapy still faces technical challenges, such as delivery efficiency, targeting specificity, and molecular stability. To address these challenges and facilitate siRNA drug development, we have developed siRNAEfficacyDB, a comprehensive database that integrates experimentally validated siRNA efficacy data. This database contains 3544 siRNA records, covering 42 target genes and 5 cell lines. It provides detailed information on siRNA sequences, target genes, inhibition efficiencies, experimental techniques, cell lines, siRNA concentrations, and incubation times. siRNAEfficacyDB offers a user‐friendly web interface that makes it easy to query, browse and analyse data, enabling efficient access to siRNA‐related information. In summary, siRNAEfficacyDB provides a useful data foundation for siRNA drug design and optimisation, serving as a valuable resource for advancing computer‐aided siRNA design research and nucleic acid drug development. siRNAEfficacyDB is freely available at https://cellknowledge.com.cn/siRNAEfficacy for non‐commercial use.
- 26 July 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 277 (Pt 4) , 134146
A protein pre-trained model-based approach for the identification of the liquid-liquid phase separation (LLPS) proteins
- 26 July 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 277 (Pt 4) , 134146
A protein pre-trained model-based approach for the identification of the liquid-liquid phase separation (LLPS) proteins
- Open Access
- 13 March 2024
- Published by MDPI AG in Information
- Vol. 15 (3) , 163
E-MuLA: An Ensemble Multi-Localized Attention Feature Extraction Network for Viral Protein Subcellular Localization
Accurate prediction of subcellular localization of viral proteins is crucial for understanding their functions and developing effective antiviral drugs. However, this task poses a significant challenge, especially when relying on expensive and time-consuming classical biological experiments. In this study, we introduced a computational model called E-MuLA, based on a deep learning network that combines multiple local attention modules to enhance feature extraction from protein sequences. The superior performance of the E-MuLA has been demonstrated through extensive comparisons with LSTM, CNN, AdaBoost, decision trees, KNN, and other state-of-the-art methods. It is noteworthy that the E-MuLA achieved an accuracy of 94.87%, specificity of 98.81%, and sensitivity of 84.18%, indicating that E-MuLA has the potential to become an effective tool for predicting virus subcellular localization.
- 13 March 2024
- Published by MDPI AG in Information
- Vol. 15 (3) , 163
Open AccessE-MuLA: An Ensemble Multi-Localized Attention Feature Extraction Network for Viral Protein Subcellular Localization
Accurate prediction of subcellular localization of viral proteins is crucial for understanding their functions and developing effective antiviral drugs. However, this task poses a significant challenge, especially when relying on expensive and time-consuming classical biological experiments. In this study, we introduced a computational model called E-MuLA, based on a deep learning network that combines multiple local attention modules to enhance feature extraction from protein sequences. The superior performance of the E-MuLA has been demonstrated through extensive comparisons with LSTM, CNN, AdaBoost, decision trees, KNN, and other state-of-the-art methods. It is noteworthy that the E-MuLA achieved an accuracy of 94.87%, specificity of 98.81%, and sensitivity of 84.18%, indicating that E-MuLA has the potential to become an effective tool for predicting virus subcellular localization.
- 11 March 2024
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 172, 108256
ncRS: A resource of non-coding RNAs in sepsis
- 11 March 2024
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 172, 108256
ncRS: A resource of non-coding RNAs in sepsis
- 12 July 2022
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 23 (4)
PSnoD: identifying potential snoRNA-disease associations based on bounded nuclear norm regularization
Many studies have proved that small nucleolar RNAs (snoRNAs) play critical roles in the development of various human complex diseases. Discovering the associations between snoRNAs and diseases is an important step toward understanding the pathogenesis and characteristics of diseases. However, uncovering associations via traditional experimental approaches is costly and time-consuming. This study proposed a bounded nuclear norm regularization-based method, called PSnoD, to predict snoRNA-disease associations. Benchmark experiments showed that compared with the state-of-the-art methods, PSnoD achieved a superior performance in the 5-fold stratified shuffle split. PSnoD produced a robust performance with an area under receiver-operating characteristic of 0.90 and an area under precision-recall of 0.55, highlighting the effectiveness of our proposed method. In addition, the computational efficiency of PSnoD was also demonstrated by comparison with other matrix completion techniques. More importantly, the case study further elucidated the ability of PSnoD to screen potential snoRNA-disease associations. The code of PSnoD has been uploaded to https://github.com/linDing-groups/PSnoD. Based on PSnoD, we established a web server that is freely accessed via http://psnod.lin-group.cn/.
- 12 July 2022
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 23 (4)
PSnoD: identifying potential snoRNA-disease associations based on bounded nuclear norm regularization
Many studies have proved that small nucleolar RNAs (snoRNAs) play critical roles in the development of various human complex diseases. Discovering the associations between snoRNAs and diseases is an important step toward understanding the pathogenesis and characteristics of diseases. However, uncovering associations via traditional experimental approaches is costly and time-consuming. This study proposed a bounded nuclear norm regularization-based method, called PSnoD, to predict snoRNA-disease associations. Benchmark experiments showed that compared with the state-of-the-art methods, PSnoD achieved a superior performance in the 5-fold stratified shuffle split. PSnoD produced a robust performance with an area under receiver-operating characteristic of 0.90 and an area under precision-recall of 0.55, highlighting the effectiveness of our proposed method. In addition, the computational efficiency of PSnoD was also demonstrated by comparison with other matrix completion techniques. More importantly, the case study further elucidated the ability of PSnoD to screen potential snoRNA-disease associations. The code of PSnoD has been uploaded to https://github.com/linDing-groups/PSnoD. Based on PSnoD, we established a web server that is freely accessed via http://psnod.lin-group.cn/.
- Open Access
- 15 March 2022
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 13, 842127
SSH2.0: A Better Tool for Predicting the Hydrophobic Interaction Risk of Monoclonal Antibody
Therapeutic antibodies play a crucial role in the treatment of various diseases. However, the success rate of antibody drug development is low partially because of unfavourable biophysical properties of antibody drug candidates such as the high aggregation tendency, which is mainly driven by hydrophobic interactions of antibody molecules. Therefore, early screening of the risk of hydrophobic interaction of antibody drug candidates is crucial. Experimental screening is laborious, time-consuming, and costly, warranting the development of efficient and high-throughput computational tools for prediction of hydrophobic interactions of therapeutic antibodies. In the present study, 131 antibodies with hydrophobic interaction experiment data were used to train a new support vector machine-based ensemble model, termed SSH2.0, to predict the hydrophobic interactions of antibodies. Feature selection was performed against CKSAAGP by using the graph-based algorithm MRMD2.0. Based on the antibody sequence, SSH2.0 achieved the sensitivity and accuracy of 100.00 and 83.97%, respectively. This approach eliminates the need of three-dimensional structure of antibodies and enables rapid screening of therapeutic antibody candidates in the early developmental stage, thereby saving time and cost. In addition, a web server was constructed that is freely available at http://i.uestc.edu.cn/SSH2/.
- 15 March 2022
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 13, 842127
Open AccessSSH2.0: A Better Tool for Predicting the Hydrophobic Interaction Risk of Monoclonal Antibody
Therapeutic antibodies play a crucial role in the treatment of various diseases. However, the success rate of antibody drug development is low partially because of unfavourable biophysical properties of antibody drug candidates such as the high aggregation tendency, which is mainly driven by hydrophobic interactions of antibody molecules. Therefore, early screening of the risk of hydrophobic interaction of antibody drug candidates is crucial. Experimental screening is laborious, time-consuming, and costly, warranting the development of efficient and high-throughput computational tools for prediction of hydrophobic interactions of therapeutic antibodies. In the present study, 131 antibodies with hydrophobic interaction experiment data were used to train a new support vector machine-based ensemble model, termed SSH2.0, to predict the hydrophobic interactions of antibodies. Feature selection was performed against CKSAAGP by using the graph-based algorithm MRMD2.0. Based on the antibody sequence, SSH2.0 achieved the sensitivity and accuracy of 100.00 and 83.97%, respectively. This approach eliminates the need of three-dimensional structure of antibodies and enables rapid screening of therapeutic antibody candidates in the early developmental stage, thereby saving time and cost. In addition, a web server was constructed that is freely available at http://i.uestc.edu.cn/SSH2/.